Patient Outcomes

Anti-Inflammatory Diet and Exercise Associated with Better Survival in Stage III Colon Cancer

Data presented at the 2025 ASCO Annual Meeting show that EDIP-based measures of dietary inflammation influence survival independently of celecoxib use.